Episode #48: New Biosimilars Available to Treat IBD (what it means for your patients)

This summer, four new biosimilar drugs became available to U.S. patients and several more are expected to hit the market soon.

Dr. Michael Weinstein interviews Laura D. Wingate, executive vice president, education, support, & advocacy for the Crohn’s & Colitis Foundation about the positive and negative implications of this development for patients.

Continue reading “Episode #48: New Biosimilars Available to Treat IBD (what it means for your patients)”

Dr. David Heydt named Medical Director for Capital Digestive Care Laboratory

Capital Digestive Care has announced that David Heydt has been named medical director of Capital Digestive Care Laboratory.

Dr. Heydt will provide clinical oversight of the laboratory in Silver Spring, Maryland, as well as clinician and staff education while assisting with innovative laboratory projects and partnerships.

Continue reading “Dr. David Heydt named Medical Director for Capital Digestive Care Laboratory”

Episode #40: New Ways to Prevent Esophageal Cancer (make screening for Barrett’s more accessible, less expensive)

Dr. Michael Weinstein interviews Dr. Prasad Iyer about new approaches to screening patients and detecting earlier stages of Barrett’s esophagus and associated dysplasia that can prevent esophageal cancer.

Continue reading “Episode #40: New Ways to Prevent Esophageal Cancer (make screening for Barrett’s more accessible, less expensive)”

Episode #38: How to Accelerate Value-Based Care (it starts with bringing together health care industry leaders)

Dr. Michael Weinstein interviews Dr. Lindee Goh, who leads the healthcare practice with Tapestry Networks, an organization that brings together health care industry leaders to learn from one another, explore new ideas, and collaborate to solve problems working across the public and private sectors.

Continue reading “Episode #38: How to Accelerate Value-Based Care (it starts with bringing together health care industry leaders)”